Host Directed Therapies for Tuberculous Meningitis.
Sign Up to like & getrecommendations! Published in 2020 at "Wellcome open research"
DOI: 10.12688/wellcomeopenres.16474.1
Abstract: A dysregulated host immune response significantly contributes to morbidity and mortality in tuberculous meningitis (TBM). Effective host directed therapies (HDTs) are critical to improve survival and clinical outcomes. Currently only one HDT, dexamethasone, is proven… read more here.
Keywords: therapies tuberculous; directed therapies; tuberculous meningitis; host ... See more keywords